• How to Order Prescriptions

---

Description

Adequan is the only joint treatment proven to reduce the inflammation and pain of degenerative joint disease, but also to help stop the degenerative process while stimulating the production of new joint fluid and new cartilage components.

• 100mg/ml.  5ml vial or 50ml vial 
• For Intramuscular Use In Horses Only. Not for Intra-Articular Use.
• Each 5 milliliters of Adequan® i.m. contains 500 mg of Polysulfated Glycosaminoglycan and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH.
• Sodium Chloride may be added to adjust tonicity.
• Polysulfated glycosaminoglycan is a naturally-occurring complex molecule that is the essential building block of the cartilage matrix.
• Adequan travels into injured joints and stimulates production of new cartilage while relieving the symptoms of non-infectious degenerative joint disease.

  

 

Why Adequan i.m. for horses?

• It's the ideal, complete treatment for non-infectious degenerative joint disease. For full prescribing information consult your veterinarian and product insert.
• Used for the treatment of
  
  • non-infectious degenerative joint dysfunction in horses
  • traumatic joint dysfunction in horses
  • associated lameness of the carpal and hock joints in horses
• Intramuscular

Dosage and Administration

The recommended dose of Adequan i.m. in horses is 500 mg every 4 days for 28 days intramuscularly.

The injection site must be thoroughly cleansed prior to injection.

Do not mix Adequan i.m. with other drugs or solvents.

Adequan® i.m. (polysulfated glycosaminoglycan) is the only FDA-approved treatment proven to relieve symptoms of non-infectious degenerative osteoarthritis, to stimulate cartilage repair and reverse the joint disease process.  There is no generic version of Adequan® i.m. Studies have not been conducted to establish safety in breeding horses.  WARNING:  Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.  Caution:  Federal law restricts this drug to use by or on the order of a licensed veterinarian.  See product package insert for full prescribing information by visiting: https://www.adequan.com.

©2020, American Regent Inc. American Regent Inc. is a trademark and Adequan® is a registered trademark of American Regent Inc.

How to Order Prescriptions

---

Description

Adequan is the only joint treatment proven to reduce the inflammation and pain of degenerative joint disease, but also to help stop the degenerative process while stimulating the production of new joint fluid and new cartilage components.

• 100mg/ml.  5ml vial or 50ml vial 
• For Intramuscular Use In Horses Only. Not for Intra-Articular Use.
• Each 5 milliliters of Adequan® i.m. contains 500 mg of Polysulfated Glycosaminoglycan and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH.
• Sodium Chloride may be added to adjust tonicity.
• Polysulfated glycosaminoglycan is a naturally-occurring complex molecule that is the essential building block of the cartilage matrix.
• Adequan travels into injured joints and stimulates production of new cartilage while relieving the symptoms of non-infectious degenerative joint disease.

Adequan^® i.m. (polysulfated glycosaminoglycan). 

Why Adequan i.m. for horses?

• It's the ideal, complete treatment for non-infectious degenerative joint disease. For full prescribing information consult your veterinarian and product insert.
• Used for the treatment of
  
  • non-infectious degenerative joint dysfunction in horses
  • traumatic joint dysfunction in horses
  • associated lameness of the carpal and hock joints in horses
• Intramuscular

Dosage and Administration

• The recommended dose of Adequan i.m. in horses is 500 mg every 4 days for 28 days intramuscularly.
• The injection site must be thoroughly cleansed prior to injection.
• Do not mix Adequan i.m. with other drugs or solvents.

Adequan® i.m. (polysulfated glycosaminoglycan) is the only FDA-approved treatment proven to relieve symptoms of non-infectious degenerative osteoarthritis, to stimulate cartilage repair and reverse the joint disease process.  There is no generic version of Adequan® i.m. Studies have not been conducted to establish safety in breeding horses.  WARNING:  Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.  Caution:  Federal law restricts this drug to use by or on the order of a licensed veterinarian.  See product package insert for full prescribing information by visiting www.adequan.com.

©2014 Luitpold Animal Health. Luitpold Animal Health (logo) is a trademark and Adequan® is a registered trademark of Luitpold Pharmaceuticals, Inc.


by Luitpold